Il rapporto
Analisi approfondite sul finanziamento aziendale, strategie di crescita e approfondimenti di mercato dalle aziende più innovative del mondo
7 report e oltre
Ginkgo Bioworks Raises $350M in Series E
Ginkgo Bioworks, a Biotech company based in 27 Drydock Avenue, Boston, MA 02210, has raised $350M in Series E at a $4.9B valuation led by Baillie Gifford, General Atlantic, Cascade Investment, T. Rowe Price, Viking Global Investors.
Ginkgo Bioworks raises $1.5B PIPE at $15B valuation
Ginkgo Bioworks raises $1.5B in PIPE at $15B valuation. Synthetic biology and organism engineering platform...
Ginkgo Bioworks raises $350M Series E at $4.9B valuation
Ginkgo Bioworks raises $350M in Series E at $4.9B valuation. Synthetic biology and organism engineering...
Ginkgo Bioworks transforms synthetic biology industry with $350M IPO at $15B valuation
Ginkgo Bioworks achieves $15B valuation through $350M IPO funding, establishing dominance in the synthetic biology market with innovative synthetic biology platform for organism design and manufacturing.
Ginkgo Bioworks Headquarters - Office Location & Address
Discover Ginkgo Bioworks's headquarters at 27 Drydock Ave, Boston, MA 02210. Synthetic biology company. Learn about the office facilities and work environment.
Umami Bioworks Headquarters - Office Location & Address
Discover Umami Bioworks's headquarters at 61 Science Park Rd, Singapore, 117525. Cell-cultured seafood production. Learn about the office facilities and work environment.
BioSynthetic Materials Raises $720M Series D for Revolutionary Synthetic Biology Technology
BioSynthetic Materials secures $720M in Series D funding at $10.8B valuation to pioneer breakthrough synthetic biology technology.
Visualizzazione di 7 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.